Michael E. Kamarck

Insider Reports History

Location
York, PA
Signature
Michael E. Kamarck, by /s/ Ron A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael E. Kamarck:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vaxcyte, Inc. Director Common Stock 5.63K $364K $64.78 13 Jun 2023 Direct
Passage BIO, Inc. Director Stock Option (right to buy) 48K 05 Jul 2022 Direct
Passage BIO, Inc. Director Director Stock Option (Right to Buy) 21.6K 25 May 2023 Direct
Vaxcyte, Inc. Director Stock Option (right to buy) 15K 13 Jun 2023 Direct
Trillium Therapeutics Inc. Director Stock Option (Right to Buy) 0 17 Nov 2021 Direct

Insider Reports Filed by Michael E. Kamarck

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PCVX Vaxcyte, Inc. 13 Jun 2023 2 $0 4 Director 15 Jun 2023, 17:53
PASG Passage BIO, Inc. 25 May 2023 1 $0 4 Director 26 May 2023, 16:31
PASG Passage BIO, Inc. 05 Jul 2022 1 $0 4 Director 06 Jul 2022, 20:32
PASG Passage BIO, Inc. 02 Jul 2022 0 $0 3 Director 06 Jul 2022, 20:30
PCVX Vaxcyte, Inc. 01 Jun 2022 2 $0 4 Director 03 Jun 2022, 16:32
TRIL Trillium Therapeutics Inc. 17 Nov 2021 1 $0 4 Director 19 Nov 2021, 12:28
PCVX Vaxcyte, Inc. 27 Oct 2021 1 $0 4 Director 29 Oct 2021, 18:11
PCVX Vaxcyte, Inc. 27 Oct 2021 0 $0 3 Director 29 Oct 2021, 18:09